Xiuling Li

Title: Xiuling Li: Innovator in Antibody and Cyclic Peptide Research

Introduction

Xiuling Li is a prominent inventor based in Jupiter, Florida, known for his significant contributions to the fields of antibody compositions and cyclic peptide conjugates. With a total of four patents to his name, Li has made strides in developing innovative solutions for various medical applications.

Latest Patents

One of Li's latest patents is focused on ROR2 antibody compositions and related methods. This invention provides antibodies, antibody fragments, or antigen-binding fragments, as well as related antibody drug conjugates (ADCs) and chimeric antigen receptors (CARs), that specifically recognize human ROR2. The invention also includes methods of using such antibodies in various diagnostic and therapeutic applications. Another notable patent involves cyclic peptide conjugates and methods of use. This invention concerns cyclic compounds and compositions comprising these cyclic compounds, linkers, and methods for treating disorders such as proliferation disorders, bone deficiency diseases, and autoimmune diseases. It also outlines methods for suppressing the growth of, or inducing apoptosis in, cells, particularly malignant cells.

Career Highlights

Throughout his career, Xiuling Li has worked with esteemed institutions such as The Scripps Research Institute and the H. Lee Moffitt Cancer Center and Research Institute, Inc. His work has significantly impacted the research community, particularly in the development of therapeutic strategies for complex diseases.

Collaborations

Li has collaborated with notable colleagues, including Christoph Rader and Lori Hazlehurst, who have contributed to his research endeavors and innovations.

Conclusion

Xiuling Li's work in antibody and cyclic peptide research exemplifies the innovative spirit of modern science. His patents reflect a commitment to advancing medical treatments and improving patient outcomes.